Kips Bay Medical IPO Will Fund U.S. Trial Of Bypass Graft-Protecting Mesh
This article was originally published in The Gray Sheet
Executive Summary
Kips Bay Medical plans to begin patient enrollment later this year for a U.S. trial of a mesh sleeve designed to improve the performance of coronary artery bypass grafts
You may also be interested in...
Kips Bay Fires Staff, Cuts Costs To Keep eSVS Mesh In The Game
The company is downsizing to keep its clinical trial for its eSVS Mesh product on track. It estimates it currently has enough funds to last it through the year, but cautions it may take months to gather patient follow-up data.
Financings In Brief
BG Medicine goes public
Financings In Brief
BG Medicine goes public